Jazz Pharmaceuticals (JAZZ) Curent Deferred Tax Liability (2012 - 2015)

Jazz Pharmaceuticals' Curent Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $9.4 million for Q3 2015.

• In Q3 2015, Curent Deferred Tax Liability rose 50.46% year-over-year to $9.4 million; the TTM figure through Sep 2015 stood at $9.4 million (up 50.46% YoY), while the FY2014 annual figure was $9.4 million, up 50.66% from the prior year.
• Curent Deferred Tax Liability was $9.4 million for Q3 2015 at Jazz Pharmaceuticals, roughly flat from $9.4 million in the prior quarter.
• In the past five years, Curent Deferred Tax Liability ranged from a high of $9.4 million in Q2 2015 to a low of $259000.0 in Q1 2013.
• Historically, Curent Deferred Tax Liability has averaged $5.3 million across 4 years, with a median of $6.3 million in 2013.
• The sharpest annual moves came in 2014 and 2015: Curent Deferred Tax Liability jumped 2316.6% in 2014, then jumped 50.46% in 2015.
• A 4-year view of Curent Deferred Tax Liability shows it stood at $275000.0 in 2012, then soared by 2176.0% to $6.3 million in 2013, then soared by 50.66% to $9.4 million in 2014, then declined by 0.14% to $9.4 million in 2015.
• The last three Curent Deferred Tax Liability figures came in at $9.4 million (Q3 2015), $9.4 million (Q2 2015), and $9.4 million (Q1 2015), per Business Quant data.